Aging and mental health Bipolar disorder Pharmaceuticals 
Mad in America
APRIL 2, 2025
Depression was sold to us as a simple problem of serotonin insufficiency, a convenient narrative that made drug companies like Eli Lilly, Forest Pharmaceuticals, and Pfizer very rich. As a former pharmaceutical advertising writer, I not only witnessed the explosive growth in antidepressant drugs, I contributed to it.
Mad in America
FEBRUARY 20, 2024
Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine. Maelys Touya was an employee of Lundbeck LLC, and Lambros Chrones was an employee of Takeda Pharmaceuticals U.S.A., The study was authored by Judith J. Additionally, Anita H.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
JANUARY 4, 2025
As such, the scandal now serves as a historical verdict on the ethics of American psychiatry, and by extension, the National Institute of Mental Health (NIMH). “The esteem held by our field in the age of modern medicine rests on the validity of our scientific pursuits.
Mad in America
DECEMBER 20, 2023
For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. What he did in this experiment was he sent ordinary people to mental hospitals and they said they were hearing words like thud, etc. But the U.K.
Mad in America
MAY 3, 2025
Establishment psychiatry does acknowledge that emotional suffering and behavioral disturbanceswhat it calls mental illnesseshave biological-psychological-social roots. medical schools. Worldwide, there are parallels to U.S. Iatrogenesis , which is defined as illness or injury caused by medical treatment.
Mad in America
OCTOBER 21, 2023
Thomas Insel, director of the National Institute of Mental Health (NIMH) from 2002-2015, acknowledged in 2011, “Whatever we’ve been doing for five decades, it ain’t working. adults now takes an antidepressant”; however, Time continued, “Mental health is getting worse by multiple metrics. As of late 2022, just 31% of U.S.
Mad in America
NOVEMBER 6, 2023
667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.
Expert insights. Personalized for you.
143 
Let's personalize your content